CDKN1B and neoplasm: TMIGD1 inhibits tumor cell proliferation and cell cycle arrest at the G2/M phase through regulating expression of p21CIP1 (cyclin-dependent kinase inhibitor 1), and p27KIP1 (cyclin-dependent kinase inhibitor 1B) [10].